نتایج جستجو برای: zygomycetes

تعداد نتایج: 349  

2011
Judit Krisch Miklós Takó Tamás Papp Csaba Vágvölgyi

β-Glucosidases (β-D-glucoside glucohydrolases) play important role in nature, including the degradation of cellulosic biomass by fungi and bacteria, breakdown of glycolipids in mammalian lysosomes, and the cleavage of glycosylated flavonoids in plants. These enzymes have broad substrate specificity, and are used in a range of biotechnological processes. The most intensively studied area of thei...

The respiratory tract is the primary mode of entry for the Zygomycetes. Pulmonary infections usually occur in the immunocompromised patient and resemble those caused by the aspergillus spp. Risk factors include hematologic problems, ketoacidosis, long- term immunosuppressive therapy, and underlying lung disease. Needle aspirates or biopsy specimens provide the best yield for diagnosis. Tissue s...

Journal: :Antimicrobial agents and chemotherapy 2002
Eric Dannaoui Javier Afeltra Jacques F G M Meis Paul E Verweij

Combinations of antimicrobial agents were tested against 35 strains of zygomycetes. The interaction between amphotericin B and rifampin was synergistic or additive. Flucytosine alone was inactive and, upon combination with amphotericin B, synergy was not achieved. The combination of amphotericin B with terbinafine was synergistic for 20% of strains, and the interaction between terbinafine and v...

Journal: :Antimicrobial agents and chemotherapy 2007
Francesco Barchiesi Elisabetta Spreghini Alfredo Santinelli Annette W Fothergill Eleonora Pisa Daniele Giannini Michael G Rinaldi Giorgio Scalise

Three isolates of zygomycetes belonging to two different genera (Rhizopus oryzae and Absidia corymbifera) were used to produce a systemic infection in neutropenic mice. On days -2 and -1 and at 2 h prior to infection, the mice received either posaconazole (POS) at doses ranging from 20 to 80 mg/kg of body weight/day or amphotericin B (AMB) at 1 mg/kg/day. Antifungal drug efficacy was assessed b...

Journal: :Therapeutics and Clinical Risk Management 2008
Stefan Langner Philipp B Staber Peter Neumeister

The rising incidence of invasive fungal infections due to the expanding population of immunocompromised hosts and the increasing prevalence of fungal resistance has led to the need for novel antifungal agents. Posaconazole, a new member of the triazole class has demonstrated in vitro activity against a broad spectrum of fungi and clinical activity against various fungal pathogens, including Asp...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید